CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $735,889
- in 3 filings
Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-10 | Huizinga Robert Bindert EVP of Research | Sale | −5,000 | $19.83 | $99K | 133,592 |
| 2021-09-10 | Huizinga Robert Bindert EVP of Research | Sale | −5,000 | $19.76 | $99K | 128,592 |
| 2021-09-10 | Solomons Neil Chief Medical Officer | Sale | −150,000 | $19.84 | $3.0M | 137,299 |
| 2021-09-07 | Martin Michael Robert Chief Business Officer | Sale | −7,500 | $18.10 | $136K | 176,861 |
| 2021-09-07 | Huizinga Robert Bindert EVP of Research | Sale | −5,000 | $18.30 | $92K | 138,592 |
| 2021-08-26 | Martin Michael Robert Chief Business Officer | Sale | −22,500 | $17.81 | $401K | 184,361 |
| 2021-08-25 | Solomons Neil Chief Medical Officer | Sale | −5,000 | $15.85 | $79K | 137,299 |
| 2021-08-09 | Solomons Neil Chief Medical Officer | Sale | −45,000 | $16.03 | $721K | 142,299 |
| 2021-08-09 | Martin Michael Robert Chief Business Officer | Sale | −5,000 | $16.01 | $80K | 206,861 |
| 2021-07-28 | Martin Michael Robert Chief Business Officer | Sale | −5,000 | $13.86 | $69K | 211,861 |
| 2021-06-22 | Martin Michael Robert Chief Business Officer | Sale | −5,000 | $13.76 | $69K | 216,861 |
| 2021-06-14 | Balakrishnan Brinda Director | Grant or award · Stock Option (right to buy) | +53,291 | 53,291 | ||
| 2021-06-14 | Hagan Joseph P Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | Walbert Timothy P Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | Billen Daniel Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | MILNE GEORGE M JR Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | Jayne David R.W. Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | MacKay-Dunn R. Hector Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-06-14 | Leversage Jill Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 | ||
| 2021-05-12 | MacKay-Dunn R. Hector Director | Purchase | +1,400 | $11.26 | $16K | 4,400 |
Page 16 of 18 · 345 trades